CYP1A2 and Parkinson disease: Palacios and colleagues [38] investigated the associations between caffeine-metabolizing genes ((CYP1A2 and N-acetyltransferase 2 (NAT2)), estrogen receptors (ESR1 and ESR2), caffeine intake and hormone replacement therapy (PMH) use and the risk of PD.